Repare Therapeutics Inc (RPTX)
3.69
+0.15
(+4.24%)
USD |
NASDAQ |
Jun 24, 09:42
Repare Therapeutics Total Assets (Quarterly): 263.08M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 263.08M |
| December 31, 2023 | 253.90M |
| September 30, 2023 | 286.41M |
| June 30, 2023 | 301.59M |
| March 31, 2023 | 336.31M |
| December 31, 2022 | 364.08M |
| September 30, 2022 | 409.16M |
| June 30, 2022 | 308.04M |
| March 31, 2022 | 337.15M |
| Date | Value |
|---|---|
| December 31, 2021 | 368.72M |
| September 30, 2021 | 295.64M |
| June 30, 2021 | 320.65M |
| March 31, 2021 | 339.07M |
| December 31, 2020 | 357.09M |
| September 30, 2020 | 370.24M |
| June 30, 2020 | 381.73M |
| March 31, 2020 | 93.57M |
| December 31, 2019 | 102.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
93.57M
Minimum
Mar 2020
409.16M
Maximum
Sep 2022
304.95M
Average
328.48M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| InMed Pharmaceuticals Inc | 13.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.13M |
| Shareholders Equity (Quarterly) | 231.95M |
| Current Ratio | 8.331 |